TRNS vs. EYPT
TRNS (Transcat, Inc.) and EYPT (Eyepoint Pharmaceuticals Inc) are both stocks. TRNS operates in Industrial Distribution (Industrials), while EYPT operates in Biotechnology (Healthcare). Over the past 10 years, TRNS returned 24.18%/yr vs -9.93%/yr for EYPT. At a 0.10 correlation, their price movements are largely independent.
Performance
TRNS vs. EYPT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TRNS achieves a 59.00% return, which is significantly higher than EYPT's -32.46% return. Over the past 10 years, TRNS has outperformed EYPT with an annualized return of 24.18%, while EYPT has yielded a comparatively lower -9.93% annualized return.
TRNS
- 1D
- -0.40%
- 1M
- 27.82%
- YTD
- 59.00%
- 6M
- 63.23%
- 1Y
- 4.94%
- 3Y*
- 0.76%
- 5Y*
- 10.04%
- 10Y*
- 24.18%
EYPT
- 1D
- -1.52%
- 1M
- -10.90%
- YTD
- -32.46%
- 6M
- -15.01%
- 1Y
- 51.97%
- 3Y*
- 27.31%
- 5Y*
- 6.14%
- 10Y*
- -9.93%
TRNS vs. EYPT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TRNS Transcat, Inc. | 59.00% | -46.35% | -3.28% | 54.27% | -23.33% | 166.52% | 8.85% | 67.51% | 33.47% | 31.94% |
EYPT Eyepoint Pharmaceuticals Inc | -32.46% | 145.23% | -67.76% | 560.29% | -71.41% | 86.02% | -57.55% | -17.99% | 75.00% | -36.84% |
Correlation
The correlation between TRNS and EYPT is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Jan 28, 2005 | 0.10 |
The correlation between TRNS and EYPT shifts across timeframes, from 0.05 (1 year) to 0.18 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
TRNS:
$0.58
EYPT:
-$3.12
TRNS:
2.54
EYPT:
29.25
TRNS:
$331.88M
EYPT:
$31.37M
TRNS:
$108.40M
EYPT:
$29.31M
TRNS:
$33.66M
EYPT:
-$239.53M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TRNS vs. EYPT — Risk / Return Rank
TRNS
EYPT
TRNS vs. EYPT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Transcat, Inc. (TRNS) and Eyepoint Pharmaceuticals Inc (EYPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TRNS | EYPT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.68 | ||
| Sortino ratioReturn per unit of downside risk | -1.05 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.18 | -0.12 |
| Calmar ratioReturn relative to maximum drawdown | 0.12 | 1.38 | -1.26 |
| Martin ratioReturn relative to average drawdown | 0.22 | 2.96 | -2.74 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| TRNS | EYPT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.10 | 0.78 | -0.68 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.23 | 0.05 | +0.18 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.57 | -0.10 | +0.67 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.17 | -0.09 | +0.26 |
Drawdowns
TRNS vs. EYPT - Drawdown Comparison
The maximum TRNS drawdown since its inception was -93.42%, roughly equal to the maximum EYPT drawdown of -97.73%. Use the drawdown chart below to compare losses from any high point for TRNS and EYPT.
Loading charts...
Drawdown Indicators
| TRNS | EYPT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.42% | -97.73% | +4.31% |
Max Drawdown (1Y)Largest decline over 1 year | -42.92% | -37.93% | -4.99% |
Max Drawdown (3Y)Largest decline over 3 years | -63.86% | -86.10% | +22.24% |
Max Drawdown (5Y)Largest decline over 5 years | -63.86% | -87.61% | +23.75% |
Max Drawdown (10Y)Largest decline over 10 years | -63.86% | -94.45% | +30.59% |
Current DrawdownCurrent decline from peak | -37.39% | -87.71% | +50.32% |
Average DrawdownAverage peak-to-trough decline | -35.38% | -76.41% | +41.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.35% | 17.60% | +4.75% |
Volatility
TRNS vs. EYPT - Volatility Comparison
Transcat, Inc. (TRNS) has a higher volatility of 18.16% compared to Eyepoint Pharmaceuticals Inc (EYPT) at 14.28%. This indicates that TRNS's price experiences larger fluctuations and is considered to be riskier than EYPT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TRNS | EYPT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.16% | 14.28% | +3.88% |
Volatility (6M)Calculated over the trailing 6-month period | 35.36% | 45.65% | -10.29% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.62% | 67.49% | -19.87% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.36% | 118.34% | -74.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 42.39% | 100.38% | -57.99% |
Dividends
TRNS vs. EYPT - Dividend Comparison
Neither TRNS nor EYPT has paid dividends to shareholders.
Financials
TRNS vs. EYPT - Financials Comparison
This section allows you to compare key financial metrics between Transcat, Inc. and Eyepoint Pharmaceuticals Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
TRNS and EYPT have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TRNS has higher volatility (18.16%) compared to EYPT (14.28%). In terms of maximum drawdown, TRNS dropped -93.42% vs EYPT's -97.73%.
EYPT currently has the higher Sharpe Ratio (0.78 vs 0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TRNS and EYPT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer